Hyper Corporation's latest marketcap:
As of 06/24/2025, Hyper Corporation's market capitalization has reached $17.78 M. According to our data, Hyper Corporation is the 36791th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 17.78 M |
| Revenue (ttm) | 45.81 M |
| Net Income (ttm) | -51,522,598.39 |
| Shares Out | 13.31 M |
| EPS (ttm) | -4.21 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/13/2025 |
Hyper Corporation's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/24/2025 | ₩17.78 M | -81.18% | 36791 |
| 12/30/2024 | ₩129.62 B | 154.84% | 24211 |
| 12/28/2023 | ₩50.86 B | 1.41% | 29439 |
| 12/29/2022 | ₩50.16 B | -55.43% | 28465 |
| 12/30/2021 | ₩112.53 B | -24.09% | 23476 |
| 12/30/2020 | ₩148.24 B | 7.14% | 18834 |
| 12/30/2019 | ₩138.36 B | -1.16% | 17227 |
| 12/28/2018 | ₩139.98 B | -3.19% | 16174 |
| 12/28/2017 | ₩144.59 B | 22.52% | 16487 |
| 12/29/2016 | ₩118.01 B | 40.85% | 16089 |
Company Profile
About Hyper Corporation Inc.
Hyper Corporation Inc. is a clinical-stage biopharmaceutical company specializing in innovative treatments and diagnostics for Alzheimer's disease (AD) and neuropathic pain. The company also operates in the electronics and food industries.
Core Business Segments
- Biopharmaceutical Development:
- Alzheimer's Disease: Anti-oligomerization of beta-amyloid, RAGE modulator, and early diagnostic kits.
- Neuropathic Pain: TRPV1 Antagonist and TRPV1 Agonist therapies.
- Electronics Retail & Wholesale:
- Products include gaming monitors, peripherals (mice, keyboards, headsets), routers, webcams, sound bars, and small home appliances.
- Convenience Food Manufacturing:
- Brands: Memories of Elementary School Tteokbokki, Newtro, and K-TOWN.
- Products: Frozen sticky rice, fish cakes, tteokbokki sauce, and raw materials for sauces.
Company Background
Originally founded in 1997 as Medifron DBT Co., Ltd., the company rebranded to Hyper Corporation Inc. in March 2024. It is headquartered in Seoul, South Korea.
Frequently Asked Questions
-
What is Hyper Corporation's (KOSDAQ-065650) current market cap?As of 06/24/2025, Hyper Corporation (including the parent company, if applicable) has an estimated market capitalization of $17.78 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Hyper Corporation (KOSDAQ-065650) rank globally by market cap?Hyper Corporation global market capitalization ranking is approximately 36791 as of 06/24/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.